Skip to main content

Neurozyl

Generic: Lidocaine HCl 4.12 %

Verified·Apr 23, 2026
Manufacturer
Jayson Pharmaceuticals Ltd.
NDC
59088-321
RxCUI
1947197
Route
TOPICAL
ICD-10 indication
R52

Affordability Check

How much will you actually pay for Neurozyl?

In 30 seconds, see every legitimate way to afford Neurozyl — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Neurozyl

What is this medication? Neurozyl is a prescription medication primarily used to manage neuropathic pain and control certain types of seizures. It is often prescribed to patients suffering from nerve damage caused by conditions like diabetes or the aftermath of shingles. By stabilizing electrical activity in the brain and influencing the way nerves send signals to the brain, it helps reduce the intensity of chronic pain sensations. In addition to its use for nerve pain and epilepsy, Neurozyl may be utilized to treat restless legs syndrome or other neurological disorders as determined by a healthcare provider. It is important for patients to take this medication exactly as directed, usually starting with a low dose that is gradually increased. Because it affects the central nervous system, users should consult with their doctor about potential side effects and avoid stopping the medication abruptly without medical supervision.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Neurozyl. Official source: DailyMed (NLM) · Label effective Jun 13, 2024

Indications and usage
INDICATIONS: Neurozyl™ Cream is indicated for the temporary relief of pain.
Dosage and administration
DOSAGE AND ADMINISTRATION: Apply a thin film to the affected area two or three times daily or as directed by a licensed healthcare practitioner.
Contraindications
CONTRAINDICATIONS: Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Warnings
WARNINGS: For external use only. Not for ophthalmic use.
Adverse reactions
ADVERSE REACTIONS: During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
Use in pregnancy
Use in Pregnancy: Teratogenic Effects; Pregnancy Category B. Reproduction studies have been performed for lidocaine in rats at doses up to 6.6 times the human dose and have revealed no evidence of harm to the fetus caused by lidocaine. There are, however, no adequate and well-controlled studies in pregnant women. Animal reproduction studies are not always predictive of human response. General consideration should be given to this fact before administering lidocaine to women of childbearing potential, especially during early pregnancy when maximum organogenesis takes place.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.